Publications by authors named "C Barger"

Background: Web-based parent training (PT) programs can strengthen parent-child relationships by equipping caregivers with knowledge and evidence-based strategies to manage behavior. Hybrid facilitation of PT includes facilitator interaction paired with self-administered and web-based PT. Web-based administrative dashboards provide users (eg, administrators, facilitators, and researchers) with an integrated platform to monitor parent progress and activities within a PT program or website.

View Article and Find Full Text PDF

TERT promoter mutations are a hallmark of glioblastoma (GBM). Accordingly, TERT and GABPB1, a subunit of the upstream mutant TERT promoter transcription factor GABP, are being considered as promising therapeutic targets in GBM. We recently reported that the expression of TERT or GABP1 modulates flux via the pentose phosphate pathway (PPP).

View Article and Find Full Text PDF

Mutations in the TERT promoter represent the genetic underpinnings of tumor cell immortality. Beyond the two most common point mutations, which selectively recruit the ETS factor GABP to activate TERT, the significance of other variants is unknown. In seven cancer types, we identify duplications of wildtype sequence within the core promoter region of TERT that have strikingly similar features including an ETS motif, the duplication length and insertion site.

View Article and Find Full Text PDF

Purpose: Telomere maintenance is a hallmark of cancer. Most tumors maintain telomere length via reactivation of telomerase reverse transcriptase (TERT) expression. Identifying clinically translatable imaging biomarkers of TERT can enable noninvasive assessment of tumor proliferation and response to therapy.

View Article and Find Full Text PDF
Article Synopsis
  • TERT promoter mutations are prevalent in wild-type IDH glioblastoma, making GABPB1 a potential therapeutic target, necessitating noninvasive imaging biomarkers for TERT modulation.
  • The study utilized various glioblastoma models and magnetic resonance spectroscopy (MRS) to assess the effects of silencing TERT and GABPB1 on metabolic changes.
  • Results indicated significant alterations in lactate and glutathione levels linked to TERT expression, suggesting these metabolites could be viable biomarkers for monitoring responses to TERT-targeted therapies in glioblastoma, with clinical implications for patient management.
View Article and Find Full Text PDF